RT Journal Article
SR Electronic
T1 Balancing Container Closure Integrity and Aesthetics for Robust Aseptic or Sterile Vial Packaging System
JF PDA Journal of Pharmaceutical Science and Technology
JO PDA J Pharm Sci Technol
FD Parenteral Drug Association (PDA)
SP pdajpst.2018.009670
DO 10.5731/pdajpst.2018.009670
A1 Yusuf Oni
A1 Xu Song
A1 Matthew Schrader
A1 Ankur Kulshrestha
A1 Jason Franck
A1 Roger Asselta
A1 Carolina Flores-Crespo
A1 Rao V. Mantri
YR 2019
UL http://journal.pda.org/content/early/2019/05/15/pdajpst.2018.009670.abstract
AB Container Closure Integrity (CCI) is one of the requirements for an aseptic or sterile packaging system. For vial-based systems, the capping process is a critical step in creating and ensuring an adequate seal with acceptable CCI. Closure Integrity Tests (CCIT) such as Dye Ingress test and Helium Leak rate test are two methods among many that, in the appropriate scenario, can provide the right methods to challenge this required attribute. The use of locked-in stopper compression (the compression under the crimp seal post-capping) enables correlation of these methods to CCI and seal quality. In fact, the overall acceptability of a seal can be evaluated using various quantitative and qualitative methods. Usually lost in these assessments is the existence of seal cosmetics as an essential additional seal quality attribute. Unacceptable cosmetic quality can have major impact on manufacturing (reduced batch output, high yield cost etc.) and user (perceived low quality and brand image, potential injury etc.) experiences. The opposite is also true that the aesthetics of a seal is impacted by the capping process. The acceptance criteria for aesthetics of a seal is subjective which makes the capping process even more complicated. Ultimately, this not only has an effect on commercial manufacturing efficiency, but also on container closure integrity. In this study, we present a simple methodology for package selection and evaluated multiple package configurations using locked-in stopper compression (through Residual Seal Force, RSF) measurements and seal aesthetics analyses. A semi-quantitative aesthetics scale was developed to enable the analysis performed. The integrity of the seals were analyzed using multiple Container Closure Integrity Test (CCIT) methods. We determined that component dimensions such as the seal lengths play a major role in obtaining proper seal aesthetics and integrity. This can ultimately enable the selection of robust packaging components with the ability to provide an adequate range or flexibility of manufacturing conditions without cosmetic defects. A failure to do this could result in high rejects during drug product visual inspection culminating in low batch yield and high costs or pose harm to patients if suitable container closure integrity is not achieved.